
zzso in terminal cancer patients may be zzso to systemic analgesics or associated with adverse drug reactions to zzso zzso analgesia has been effectively used in such patients for pain zzso However, this method does not provide pain relief to all zzso The efficacy and complications of continuous zzso analgesia were evaluated for expanding efficacy in terminal cancer zzso 

The charts of patients who received zzso analgesia for over 5 years for the control of terminal cancer pain were reviewed zzso 

zzso patients received zzso zzso zzso The mean duration for zzso zzso was zzso zzso zzso The dose of zzso zzso increased by zzso per zzso The efficacy of zzso analgesia at 2 weeks follow up revealed improved pain control zzso as the zzso equivalent drug dose dropped from zzso zzso to zzso zzso zzso at 2 weeks follow zzso zzso after 2 weeks institution of zzso zzso there was a significant reduction in the proportion of patients with severe pain, from zzso to zzso zzso 

zzso analgesia was an effective pain control method in patients with terminal cancer pain, however, a zzso zzso for the control of zzso pain in zzso 

